Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

MLA

Gherardi, Giovanni, et al. “Evaluation of in Vitro Activity of Ceftolozane-Tazobactam Compared to Other Antimicrobial Agents against Pseudomonas Aeruginosa Isolates from Cystic Fibrosis Patients.” Diagnostic Microbiology and Infectious Disease, vol. 94, no. 3, July 2019, pp. 297–303. EBSCOhost, https://doi.org/10.1016/j.diagmicrobio.2019.01.012.

APA

Gherardi, G., Linardos, G., Pompilio, A., Fiscarelli, E., & Di Bonaventura, G. (2019). Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagnostic Microbiology and Infectious Disease, 94(3), 297–303. https://doi.org/10.1016/j.diagmicrobio.2019.01.012

Chicago

Gherardi, Giovanni, Giulia Linardos, Arianna Pompilio, Ersilia Fiscarelli, and Giovanni Di Bonaventura. 2019. “Evaluation of in Vitro Activity of Ceftolozane-Tazobactam Compared to Other Antimicrobial Agents against Pseudomonas Aeruginosa Isolates from Cystic Fibrosis Patients.” Diagnostic Microbiology and Infectious Disease 94 (3): 297–303. doi:10.1016/j.diagmicrobio.2019.01.012.